Published in J Virol on November 01, 1981
Adenovirus 2 early region 1A stimulates expression of both viral and cellular genes. EMBO J (1984) 3.03
Negative regulatory sequences in the EIa-inducible enhancer of the adenovirus-2 early EIIa promoter. Nucleic Acids Res (1986) 1.82
Cycloheximide stimulates early adenovirus transcription if early gene expression is allowed before treatment. J Virol (1983) 1.43
Expression of the E4 gene is required for establishment of soft-agar colony-forming rat cell lines transformed by the adenovirus 12 E1 gene. J Virol (1984) 1.05
Shuffling adenovirus promoters: a viral recombinant with early region 1A under late transcriptional control. EMBO J (1983) 1.00
Control of adenovirus gene expression: cellular gene products restrict expression of adenovirus host range mutants in nonpermissive cells. J Virol (1983) 0.99
Establishment and characterization of hamster cell lines transformed by restriction endonuclease fragments of adenovirus 5. J Virol (1984) 0.98
Detection of specific sequences among DNA fragments separated by gel electrophoresis. J Mol Biol (1975) 503.08
Labeling deoxyribonucleic acid to high specific activity in vitro by nick translation with DNA polymerase I. J Mol Biol (1977) 205.11
Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J Gen Virol (1977) 41.93
Rates of formation and thermal stabilities of RNA:DNA and DNA:DNA duplexes at high concentrations of formamide. Nucleic Acids Res (1977) 15.92
A procedure for the isolation of mammalian messenger ribonucleic acid. Biochemistry (1972) 14.47
An adenovirus type 5 early gene function regulates expression of other early viral genes. Proc Natl Acad Sci U S A (1979) 13.21
Pre-early adenovirus 5 gene product regulates synthesis of early viral messenger RNAs. Cell (1979) 12.83
Structure of the adenovirus 2 early mRNAs. Cell (1978) 10.54
Viral DNA in transformed cells. II. A study of the sequences of adenovirus 2 DNA IN NINE LINES OF TRANSFORMED RAT CELLS USING SPECIFIC FRAGMENTS OF THE VIRAL GENOME;. J Mol Biol (1974) 4.39
Regulation of the appearance of cytoplasmic RNAs from region 1 of the adenovirus 2 genome. J Mol Biol (1978) 4.30
Control of adenovirus early gene expression: a class of immediate early products. Cell (1980) 3.41
Adenovirus 5 DNA sequences present and RNA sequences transcribed in transformed human embryo kidney cells (HEK-Ad-5 or 293). Virology (1979) 3.34
Immunological identification of two adenovirus 2-induced early proteins possibly involved in cell transformation. Nature (1976) 3.01
Regulation of the primary expression of the early adenovirus transcription units. J Virol (1979) 2.92
Transformation with specific fragments of adenovirus DNAs. I. Isolation of specific fragments with transforming activity of adenovirus 2 and 5 DNA. Gene (1977) 2.86
Purification of specific adenovirus 2 RNAs by preparative hybridization and selective thermal elution. Nucleic Acids Res (1979) 2.78
Proteins and messenger RNAs of the transforming region of wild-type and mutant adenoviruses. J Mol Biol (1980) 2.73
Hybridization maps of early and late messenger RNA sequences on the adenovirus type 2 genome. J Mol Biol (1976) 2.58
Regulation of early adenovirus transcription: a protein product of early region 2 specifically represses region 4 transcription. Proc Natl Acad Sci U S A (1980) 2.42
Synthesis of a structural adenovirus polypeptide in the absence of viral DNA replication. Virology (1978) 2.09
Adenovirus early gene products may control viral mRNA accumulation and translation in vivo. Cell (1981) 1.93
Synthesis and genomic site for an adenovirus type 2 early glycoprotein. J Mol Biol (1980) 1.82
Analysis of RNA initiated in isolated mouse myeloma nuclei using purine nucleoside 5'[gamma-S]triphosphates as affinity probes. Cell (1978) 1.73
Identification of the adenovirus early proteins and their genomic map positions. Virology (1980) 1.67
Tumor antigens of human Ad5 in transformed cells and in cells infected with transformation-defective host-range mutants. Cell (1979) 1.46
Viral DNA sequences in adenovirus-transformed cells. Cold Spring Harb Symp Quant Biol (1980) 1.35
In vitro synthesis of adenovirus type 5 T antigens. I. Translation of early region 1-specific rna from lytically infected cells. J Virol (1981) 1.35
Physical location of host-range mutations of adenovirus type 5; deletion and marker-rescue mapping. Virology (1980) 1.27
In vitro synthesis of adenovirus type 5 T antigens. II. Translation of virus-specific RNA from cells transformed by fragments of adenovirus type 5 DNA. J Virol (1981) 0.82
Polyadenylic acid sequences: role in conversion of nuclear RNA into messenger RNA. Science (1971) 10.54
HCAR and MCAR: the human and mouse cellular receptors for subgroup C adenoviruses and group B coxsackieviruses. Proc Natl Acad Sci U S A (1997) 6.92
Complete sequence of the staphylococcal gene encoding protein A. A gene evolved through multiple duplications. J Biol Chem (1984) 5.94
Genes specifically expressed at growth arrest of mammalian cells. Cell (1988) 5.61
Translation of MuLV and MSV RNAs in nuclease-treated reticulocyte extracts: enhancement of the gag-pol polypeptide with yeast suppressor tRNA. Cell (1978) 5.31
Evidence that hepatitis C virus resistance to interferon is mediated through repression of the PKR protein kinase by the nonstructural 5A protein. Virology (1997) 5.26
Virus-receptor interaction in an adenovirus system. J Virol (1968) 4.69
Control of PKR protein kinase by hepatitis C virus nonstructural 5A protein: molecular mechanisms of kinase regulation. Mol Cell Biol (1998) 4.52
Addition of polyadenylate sequences to virus-specific RNA during adenovirus replication. Proc Natl Acad Sci U S A (1971) 4.48
Binding of the influenza virus NS1 protein to double-stranded RNA inhibits the activation of the protein kinase that phosphorylates the elF-2 translation initiation factor. Virology (1995) 4.43
Cloning of the human cDNA for the U1 RNA-associated 70K protein. EMBO J (1986) 4.43
Malignant transformation by a mutant of the IFN-inducible dsRNA-dependent protein kinase. Science (1992) 4.42
Isolation and characterization of adenovirus messenger ribonucleic acid in productive infection. J Virol (1972) 3.83
Early events of virus-cell interaction in an adenovirus system. J Virol (1969) 3.68
Molecular mechanisms of interferon resistance mediated by viral-directed inhibition of PKR, the interferon-induced protein kinase. Pharmacol Ther (1998) 3.64
Antibodies to human c-myc oncogene product: evidence of an evolutionarily conserved protein induced during cell proliferation. Science (1984) 3.63
Tumor suppressor function of the interferon-induced double-stranded RNA-activated protein kinase. Proc Natl Acad Sci U S A (1993) 3.62
Multiple promoters direct tissue-specific expression of the rat BDNF gene. Neuron (1993) 3.44
Structural proteins of adenoviruses. X. Isolation and topography of low molecular weight antigens from the virion of adenovirus type 2. Virology (1973) 3.26
Nuclear localization and DNA binding properties of a protein expressed by human c-myc oncogene. Science (1984) 3.24
Unrelated animal viruses share receptors. Nature (1976) 3.24
CHOP (GADD153) and its oncogenic variant, TLS-CHOP, have opposing effects on the induction of G1/S arrest. Genes Dev (1994) 3.12
Specific alterations of coxsackievirus B3 eluted from HeLa cells. J Virol (1971) 3.10
A new species of virus-coded low molecular weight RNA from cells infected with adenovirus type 2. Cell (1976) 3.00
Gene for staphylococcal protein A. Proc Natl Acad Sci U S A (1983) 2.97
Large-scale monitoring of host cell gene expression during HIV-1 infection using cDNA microarrays. Virology (2000) 2.92
Hydroxyapatite chromatography and formamide denaturation of adenovirus DNA. J Virol (1973) 2.90
Mammalian eukaryotic initiation factor 2 alpha kinases functionally substitute for GCN2 protein kinase in the GCN4 translational control mechanism of yeast. Proc Natl Acad Sci U S A (1993) 2.90
Transformation reveals a chromosomal locus of the gene(s) for methicillin resistance in Staphylococcus aureus. J Bacteriol (1975) 2.83
RNA synthesis and processing in adenovirus-infected cells. Cold Spring Harb Symp Quant Biol (1975) 2.82
Processing of adenovirus specific nuclear RNA during virus replication. Virology (1972) 2.71
Inhibition of influenza virus ribonucleic acid polymerase by ribavirin triphosphate. Antimicrob Agents Chemother (1977) 2.71
An improved positive selection plasmid vector constructed by oligonucleotide mediated mutagenesis. Nucleic Acids Res (1983) 2.69
Cell proliferation inhibited by MyoD1 independently of myogenic differentiation. Nature (1990) 2.68
Structural proteins of adenoviruses. IV. Sequential degradation of the adenovirus type 2 virion. Virology (1970) 2.65
Translational control of viral gene expression in eukaryotes. Microbiol Mol Biol Rev (2000) 2.63
Further evidence on the nuclear origin and transfer to the cytoplasm of polyadenylic acid sequences in mammalian cell RNA. J Mol Biol (1973) 2.61
Hybridization maps of early and late messenger RNA sequences on the adenovirus type 2 genome. J Mol Biol (1976) 2.58
A comprehensive view of regulation of gene expression by double-stranded RNA-mediated cell signaling. J Biol Chem (2001) 2.58
Isolation and characterization of multiple human genes homologous to the oncogenes of avian erythroblastosis virus. EMBO J (1983) 2.52
Controls of RNA splicing and termination in the major late adenovirus transcription unit. Nature (1981) 2.49
Early interaction between animal viruses and cells. Monogr Virol (1974) 2.43
Transfection of Staphylococcus aureus with bacteriophage deoxyribonucleic acid. J Bacteriol (1972) 2.42
The binding of double-stranded RNA and adenovirus VAI RNA to the interferon-induced protein kinase. Eur J Biochem (1989) 2.42
How hepatitis C virus counteracts the interferon response: the jury is still out on NS5A. Virology (2001) 2.39
Regulation of G1 progression by E2A and Id helix-loop-helix proteins. EMBO J (1994) 2.33
Biochemical and genetic evidence for complex formation between the influenza A virus NS1 protein and the interferon-induced PKR protein kinase. J Interferon Cytokine Res (1998) 2.32
The release of growth arrest by microinjection of adenovirus E1A DNA. EMBO J (1985) 2.32
Protein A mutants of Staphylococcus aureus. J Bacteriol (1971) 2.32
Differentiation of cardiac chronotropic and inotropic effects of beta-adrenoceptor agonists. Naunyn Schmiedebergs Arch Pharmacol (1977) 2.26
Intermediates in adenovirus assembly. J Virol (1976) 2.26
Structural proteins of adenoviruses. I. Purification and characterization of the adenovirus type 2 hexon antigen. Virology (1967) 2.25
Identification of cells in rat brain and peripheral tissues expressing mRNA for members of the nerve growth factor family. Neuron (1990) 2.22
Factors affecting competence for transformation in Staphylococcus aureus. J Bacteriol (1974) 2.22
Inhibition of double-stranded RNA-dependent protein kinase PKR by vaccinia virus E3: role of complex formation and the E3 N-terminal domain. Mol Cell Biol (1998) 2.21
The three influenza virus polymerase (P) proteins not associated with viral nucleocapsids in the infected cell are in the form of a complex. J Virol (1987) 2.20
Adenovirus VAI RNA complexes with the 68 000 Mr protein kinase to regulate its autophosphorylation and activity. EMBO J (1987) 2.17
Competence for transfection in Staphylococcus aureus. J Bacteriol (1973) 2.16
Global impact of influenza virus on cellular pathways is mediated by both replication-dependent and -independent events. J Virol (2001) 2.13
Synthesis of a structural adenovirus polypeptide in the absence of viral DNA replication. Virology (1978) 2.09
Loss of HNF-1alpha function in mice leads to abnormal expression of genes involved in pancreatic islet development and metabolism. Diabetes (2001) 2.08
Transcription signals in embryonic Xenopus laevis U1 RNA genes. EMBO J (1985) 2.07
Coexpression of the sis and myc proto-oncogenes in developing human placenta suggests autocrine control of trophoblast growth. Cell (1985) 2.06
Purification and partial characterization of a cellular inhibitor of the interferon-induced protein kinase of Mr 68,000 from influenza virus-infected cells. Proc Natl Acad Sci U S A (1990) 2.05
NS5A, a nonstructural protein of hepatitis C virus, binds growth factor receptor-bound protein 2 adaptor protein in a Src homology 3 domain/ligand-dependent manner and perturbs mitogenic signaling. Proc Natl Acad Sci U S A (1999) 2.03
The 58,000-dalton cellular inhibitor of the interferon-induced double-stranded RNA-activated protein kinase (PKR) is a member of the tetratricopeptide repeat family of proteins. Mol Cell Biol (1994) 2.03
Assembly of adenoviruses. J Virol (1973) 2.02
Evolutionary studies of the nerve growth factor family reveal a novel member abundantly expressed in Xenopus ovary. Neuron (1991) 2.02
Infection of Macaca nemestrina by human immunodeficiency virus type-1. Science (1992) 2.01
Metabolism and expression of RNA polymerase II transcripts in influenza virus-infected cells. Mol Cell Biol (1984) 1.97
The cellular 68,000-Mr protein kinase is highly autophosphorylated and activated yet significantly degraded during poliovirus infection: implications for translational regulation. J Virol (1989) 1.96
Antiapoptotic and oncogenic potentials of hepatitis C virus are linked to interferon resistance by viral repression of the PKR protein kinase. J Virol (1999) 1.96
Molecular cloning and neurotrophic activities of a protein with structural similarities to nerve growth factor: developmental and topographical expression in the brain. Proc Natl Acad Sci U S A (1990) 1.94
Molecular association between transplantation antigens and cell surface antigen in adenovirus-transformed cell line. Proc Natl Acad Sci U S A (1978) 1.94
Adenovirus early gene products may control viral mRNA accumulation and translation in vivo. Cell (1981) 1.93
Control of the interferon-induced 68-kilodalton protein kinase by the HIV-1 tat gene product. Science (1990) 1.93
Structure and function of virion proteins of adenoviruses. Prog Exp Tumor Res (1973) 1.91
The growth arrest-specific gene, gas1, is involved in growth suppression. Cell (1992) 1.89
Mechanism of the arginine requirement for adenovirus synthesis. I. Synthesis of structural proteins. J Virol (1971) 1.84
Synthesis and genomic site for an adenovirus type 2 early glycoprotein. J Mol Biol (1980) 1.82
Primary structural relationships may reflect similar DNA replication strategies. Virology (1986) 1.81
Location of sequences on the adenovirus genome coding for the 5.5S RNA. Cell (1975) 1.81
Myelinated nerve fibres in the CNS. Prog Neurobiol (1993) 1.79
Differential expression of mRNAs for neurotrophins and their receptors after axotomy of the sciatic nerve. J Cell Biol (1993) 1.78
Characterization of small plasmids from Staphylococcus aureus. Gene (1978) 1.78
High expression of functional adenovirus DNA polymerase and precursor terminal protein using recombinant vaccinia virus. Nucleic Acids Res (1988) 1.77
Increased levels of messenger RNAs for neurotrophic factors in the brain during kindling epileptogenesis. Neuron (1991) 1.74
Identification of the in vitro translation products of adenovirus mRNA by immunoprecipitation. J Virol (1975) 1.74
Small RNAs analysis in CLL reveals a deregulation of miRNA expression and novel miRNA candidates of putative relevance in CLL pathogenesis. Leukemia (2007) 1.73
A study of 136 cases of adder bite treated in Swedish hospitals during one year. Acta Med Scand (1981) 1.71
Synthesis of complementary RNA sequences during productive adenovirus infection. Proc Natl Acad Sci U S A (1974) 1.70
Muscle-derived neurotrophin-4 as an activity-dependent trophic signal for adult motor neurons. Science (1995) 1.70
Viral DNA sequences and gene products in hamster cells transformed by adenovirus type 2. J Virol (1978) 1.69
Control of adenovirus early gene expression: posttranscriptional control mediated by both viral and cellular gene products. Mol Cell Biol (1981) 1.68